T1	Premise 1175 1452	At 4 years, 64 (18%) of 353 patients on combined therapy and 39 (12%) of 337 on endocrine-alone therapy had moderate to severe urinary bother (p=0.005), and 16 (4%) of 355 on combined therapy and five (2%) of 338 on endocrine treatment alone had pain while urinating (p=0.024).
T2	Premise 1453 1590	37 (11%) of 350 in the combined group and 23 (7%) of 35 in the endocrine-only group had overall bother from all bowel symptoms (p=0.022).
T3	Premise 1591 1725	281 (85%) of 332 in the combined-treatment group and 227 (72%) of 313 in the endocrine-only group had erectile dysfunction (p=0.0002).
T4	Premise 1726 1874	Quality of life at 4 years was similar, with the exception of decreased social function in patients receiving endocrine treatment plus radiotherapy.
T6	Claim 1875 2007	Although addition of radiotherapy to endocrine treatment significantly increased some treatment-related symptoms, none were serious.
R1	Support Arg1:T1 Arg2:T6	
R2	Support Arg1:T4 Arg2:T6	
R3	Support Arg1:T3 Arg2:T6	
R4	Support Arg1:T2 Arg2:T6	
T5	Claim 2070 2213	the increase of symptoms seems acceptable and has little extra effect on quality of life after 4 years compared with endocrine treatment alone.
R5	Support Arg1:T6 Arg2:T5	
